Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonothrombolysis with Microbubbles in Acute Ischemic Stroke
NCT01678495Phase 2Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Aug 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of sulfur hexafluoride in ischemic stroke, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Recanalization rate at 90 days. Started Aug 2012; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01678495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678495.